Atlas Trials

SGLT2 Inhibition in Hemodialysis

Clinical trial NCT05179668 · COMPLETED

Trial details

NCT number
NCT05179668
Sponsor
Medical University of Vienna
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney FailureHemodialysisDiabetes Mellitus, Type 2Chronic Kidney DiseaseLeft Ventricular Hypertrophy
Start date
2022-10-01
Primary completion
2025-07-11
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.